Literature DB >> 25699982

Circulating Biomarkers Predictive of Postoperative Atrial Fibrillation.

Mohit K Turagam1, Mahek Mirza, Paul H Werner, Jasbir Sra, David C Kress, A Jamil Tajik, Arshad Jahangir.   

Abstract

Postoperative atrial fibrillation (PoAF), a common complication of cardiac surgery, contributes significantly to morbidity, mortality, and increasing healthcare costs. Despite advances in surgical and medical management, the overall incidence of PoAF has not changed significantly, partly because of the limited understanding of mechanisms underlying acute surgery-related factors, such as myocardial injury, inflammation, sympathetic activation, and oxidative stress, which play an important role in the initiation of PoAF, whereas a preexisting atrial substrate appears to be more important in the maintenance of this dysrhythmia. Thus, in a majority of patients, PoAF becomes a manifestation of an underlying arrhythmogenic substrate that is unmasked after acute surgical stress. As such, the ability to identify which patients have this proarrhythmic substrate and are, therefore, at high risk for developing AF postoperatively, is important for the improved selection for prophylactic interventions, closer monitoring for complications, and establishing the probability of AF in the long term. This review highlights the role of the underlying substrate in promoting PoAF, proposed mechanisms, and the potential role of serum biomarkers to identify patients at risk for PoAF.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 25699982      PMCID: PMC4944526          DOI: 10.1097/CRD.0000000000000059

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  148 in total

1.  Prediction of atrial fibrillation after coronary artery bypass grafting by measuring atrial peptide levels and preoperative atrial dimensions.

Authors:  T Hakala; A Hedman; A Turpeinen; R Kettunen; O Vuolteenaho; M Hippeläinen
Journal:  Eur J Cardiothorac Surg       Date:  2002-12       Impact factor: 4.191

2.  Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis.

Authors:  Kwok M Ho; Jen Aik Tan
Journal:  Circulation       Date:  2009-03-30       Impact factor: 29.690

3.  Is altered atrial microRNA-ome a critical contributor to the pathophysiology of atrial fibrillation?

Authors:  Dobromir Dobrev
Journal:  Basic Res Cardiol       Date:  2012-07-17       Impact factor: 17.165

4.  Role of miR-21 in the pathogenesis of atrial fibrosis.

Authors:  Oliver Adam; Björn Löhfelm; Thomas Thum; Shashi K Gupta; Sarah-Lena Puhl; Hans-Joachim Schäfers; Michael Böhm; Ulrich Laufs
Journal:  Basic Res Cardiol       Date:  2012-07-04       Impact factor: 17.165

5.  Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.

Authors:  Begoña López; Arantxa González; Javier Beaumont; Ramón Querejeta; Mariano Larman; Javier Díez
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

6.  MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation.

Authors:  Kristin Dawson; Reza Wakili; Balázs Ordög; Sebastian Clauss; Yu Chen; Yuki Iwasaki; Niels Voigt; Xiao Yan Qi; Moritz F Sinner; Dobromir Dobrev; Stefan Kääb; Stanley Nattel
Journal:  Circulation       Date:  2013-03-04       Impact factor: 29.690

7.  N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.

Authors:  Kristen K Patton; Patrick T Ellinor; Susan R Heckbert; Robert H Christenson; Christopher DeFilippi; John S Gottdiener; Richard A Kronmal
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

8.  Familial atrial fibrillation is a genetically heterogeneous disorder.

Authors:  Dawood Darbar; Kathleen J Herron; Jeffrey D Ballew; Arshad Jahangir; Bernard J Gersh; Win-K Shen; Stephen C Hammill; Douglas L Packer; Timothy M Olson
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

9.  Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation.

Authors:  Yong Li; Zhao Jian; Zong Ying Yang; Lin Chen; Xue Feng Wang; Rui Yan Ma; Ying Bin Xiao
Journal:  Cardiology       Date:  2013-04-06       Impact factor: 1.869

10.  Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure.

Authors:  Young Keun On; Eun-Seok Jeon; Sang Yeub Lee; Dae-Hee Shin; Jin-Oh Choi; Jidong Sung; June Soo Kim; Kiick Sung; Pyowon Park
Journal:  J Thorac Cardiovasc Surg       Date:  2009-06       Impact factor: 5.209

View more
  14 in total

Review 1.  Immunopathogenesis and biomarkers of recurrent atrial fibrillation following ablation therapy in patients with preexisting atrial fibrillation.

Authors:  John H Rosenberg; John H Werner; Gilman D Plitt; Victoria V Noble; Jordan T Spring; Brooke A Stephens; Aleem Siddique; Helenmari L Merritt-Genore; Michael J Moulton; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-12-29

Review 2.  Perioperative Biomarkers Predicting Postoperative Atrial Fibrillation Risk After Coronary Artery Bypass Grafting: A Narrative Review.

Authors:  Muhammad S Khan; Kennosuke Yamashita; Vikas Sharma; Ravi Ranjan; Craig H Selzman; Derek J Dosdall
Journal:  J Cardiothorac Vasc Anesth       Date:  2019-09-18       Impact factor: 2.628

Review 3.  Pharmacological strategies for prevention of postoperative atrial fibrillation.

Authors:  Mohit K Turagam; Francis X Downey; David C Kress; Jasbir Sra; A Jamil Tajik; Arshad Jahangir
Journal:  Expert Rev Clin Pharmacol       Date:  2015-03       Impact factor: 5.045

4.  Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Mark Ainslie; Virginia Mplani; Georgia Karavasili; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-11-28       Impact factor: 3.327

5.  Prognostic value of interleukin-6 in atrial fibrillation: A cohort study and meta-analysis.

Authors:  Xiaoyue Jia; Xi Cheng; Na Wu; Ying Xiang; Long Wu; Bin Xu; Chengying Li; Zhihui Zhang; Shifei Tong; Li Zhong; Yafei Li
Journal:  Anatol J Cardiol       Date:  2021-12       Impact factor: 1.596

6.  Selective downregulation of mitochondrial electron transport chain activity and increased oxidative stress in human atrial fibrillation.

Authors:  Larisa Emelyanova; Zain Ashary; Milanka Cosic; Ulugbek Negmadjanov; Gracious Ross; Farhan Rizvi; Susan Olet; David Kress; Jasbir Sra; A Jamil Tajik; Ekhson L Holmuhamedov; Yang Shi; Arshad Jahangir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

7.  Inflammatory Cytokines During Cardiac Rehabilitation After Heart Surgery and Their Association to Postoperative Atrial Fibrillation.

Authors:  Vittorio Racca; Anna Torri; Paola Grati; Claudia Panzarino; Ivana Marventano; Marina Saresella; Paolo Castiglioni
Journal:  Sci Rep       Date:  2020-05-25       Impact factor: 4.379

Review 8.  RNAs and Gene Expression Predicting Postoperative Atrial Fibrillation in Cardiac Surgery Patients Undergoing Coronary Artery Bypass Grafting.

Authors:  Muhammad Shuja Khan; Kennosuke Yamashita; Vikas Sharma; Ravi Ranjan; Derek James Dosdall
Journal:  J Clin Med       Date:  2020-04-16       Impact factor: 4.241

Review 9.  Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology.

Authors:  Iacopo Fabiani; Alessandro Colombo; Giulia Bacchiani; Carlo Maria Cipolla; Daniela Maria Cardinale
Journal:  J Clin Med       Date:  2019-12-23       Impact factor: 4.241

10.  Noninvasive biomarker-based risk stratification for development of new onset atrial fibrillation after coronary artery bypass surgery.

Authors:  Farhan Rizvi; Mahek Mirza; Susan Olet; Melissa Albrecht; Stacie Edwards; Larisa Emelyanova; David Kress; Gracious R Ross; Ekhson Holmuhamedov; A Jamil Tajik; Bijoy K Khandheria; Arshad Jahangir
Journal:  Int J Cardiol       Date:  2020-01-07       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.